Alpine to hold an ALPN-202 Investor Event on Friday, June 4 at 7:00pm EDT SEATTLE --(BUSINESS WIRE)--Jun. 4, 2021-- Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases,